CAPIVASERTIB vs CAPMATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CAPIVASERTIB vs CAPMATINIB: Safety Overview
| Metric | CAPIVASERTIB | CAPMATINIB |
|---|---|---|
| Total FAERS Reports | 1,691 | 2,301 |
| Deaths Reported | 285 | 583 |
| Death Rate | 16.9% | 25.3% |
| Hospitalizations | 464 | 388 |
| Average Patient Age | 66.2 yrs | 71.9 yrs |
| % Female Patients | 94.6% | 53.9% |
| FDA Approval Date | Nov 16, 2023 | May 6, 2020 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Novartis Pharmaceuticals Corporation |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |